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Purpose: The aim of this study was to study the aqueous cytokine and chemokine composition in patients with uveitis
associated with tuberculosis (TAU).
Methods: We present a prospective case series of consecutive new patients with active uveitis presenting at a single
tertiary center (January 1, 2008-January 1, 2010). Patients with no ocular pathology other than cataracts were enrolled as
non-inflammatory controls. Aqueous samples were taken from all study subjects and analyzed using a magnetic color-
bead-based multiplex assay for cytokine and chemokine concentrations.
Results: Twenty-five eyes of 25 patients with active uveitis with suspected tuberculosis (TB) and 23 non-inflammatory
controls were enrolled. Ten patients tested positive on a tuberculin skin test and interferon-gamma release assay; all ten
patients responded to anti-TB treatment with no recurrences (TAU). The remaining 15 eyes were negative for the above
tests and had no other underlying causes for uveitis found on clinical evaluation and investigations; therefore, they were
classified as “idiopathic uveitis” (IU). The TAU group showed significantly higher levels of interleukin-6 (IL-6; p=0.047),
interleukin-8 (CXCL8; p=0.001), monokine induced by interferon-gamma (CXCL9; p=0.001), and interferon-gamma-
induced protein 10 (IP-10 or CXCL10; p=0.002), compared to the controls. The IU group showed significantly higher
levels of IL-6 (p=0.008), monocyte chemotactic protein-1 (CCL2; p=0.036), CXCL8 (p=0.001), and IL-9 (p=0.045), and
significantly lower levels of IL-2 (p=0.011), IL-12 (p=0.001), and tumor necrosis factor (TNF)-α (p=0.001), compared to
the controls. Heat map analysis revealed significant differences in aqueous cytokine and chemokine concentrations among
the TAU patients, the IU patients, and the controls.
Conclusions: In our study population, aqueous cytokine and chemokine analyses suggest that subjects with uveitis
associated with TB who respond to anti-TB therapy do not have an active ocular tuberculous infection, but rather an
autoimmune-related ocular inflammation that may be triggered by TB.
Uveitis is a sight-threatening disease that accounts for
more than 10% of blindness worldwide [1]. While uveitis may
be  associated  with  infections  or  autoimmune  or  systemic
diseases, up to 60% of all patients have no underlying etiology
detected, and the uveitis is thus labeled “idiopathic” [1-3]. In
Singapore, a developed country with an intermediate burden
of tuberculosis (TB), the association of TB with idiopathic
uveitis is controversial [4,5]. Although no disease other than
manifest or latent TB is found, the diagnosis of ocular TB
cannot  be  confirmed,  as  there  is  often  no  evidence  of
Mycobacterium tuberculosis from their ocular samples [6].
The detection of Mycobacterium tuberculosis is rare [7], as
methods such as culture on Lowenstein Jenson agar, acid-fast
bacilli (AFB) smear, and demonstration of Mycobacterium
tuberculosis nucleic acid using polymerase chain reaction
(PCR) have low sensitivities [8]. Thus, diagnoses of uveitis
associated with TB (TAU) are mostly presumptive, i.e., made
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with  a  positive  tuberculin  skin  test  (TST),  a  positive
interferon-gamma  release  assay  (IGRA)  test,  findings
suggestive of previous pulmonary TB on chest X-ray (CXR),
and/or concomitant active extraocular TB infection [4,6,9,
10].
The aqueous humor is important for the maintenance of
both physiologic function and metabolic homeostasis within
the anterior chamber [11]. Components of the aqueous humor
are a reflection of the state of intraocular tissues, and they
change rapidly with the development or progression of disease
[12]. Abnormal concentrations of various cytokines have been
reported in the aqueous associated with different forms of
uveitis [13-20], and distinct cytokine profiles may be used to
identify specific diseases [15].
In this pilot study, we compared the aqueous cytokine and
chemokine compositions in patients with TAU and no other
causes of inflammation to the aqueous from patients with no
ocular inflammation, as well as aqueous from patients with
idiopathic uveitis with no evidence of TB or other diseases.
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565METHODS
We  conducted  a  prospective,  comparative  case  series  of
consecutive  patients  with  active  uveitis  presenting  at  the
Singapore  National  Eye  Centre  Ocular  Inflammation  and
Immunology Service, from January 1, 2008, to January 1,
2010.  The  study  was  approved  by  the  local  Institutional
Review Board and performed in accordance with the tenets of
the Declaration of Helsinki. Informed consent was obtained
from all subjects. All new patients who present to our facility
with uveitis undergo a systemic and clinical examination, with
investigations as previously described [4]. In this study, we
noted patient demographics, clinical history, and features of
uveitis, using the criteria set by the Standardization of Uveitis
Nomenclature (SUN) working group for scoring the anatomic
location, onset, duration, course, and activity [21]. Patients
with no ocular pathology other than cataract were enrolled as
non-inflammatory controls.
All  subjects  underwent  investigations,  including
complete blood count, erythrocyte sedimentation rate, liver
enzyme  panel,  infectious  disease  screen  (which  included
Venereal  Disease  Research  Laboratory  and  enzyme
immunoassay test for syphilis, TST, urine microscopy), and
chest X-ray. Other tests were performed as well, such as
human leukocyte antigen (HLA) B27 screen, IGRA tests,
AFB smear from throat swabs, and PCR assays for TB DNA
from aqueous humor. As part of our routine investigations,
TST was performed using intradermal injection of 0.1 ml (2
tuberculin  units)  purified  protein  derivative  (RT23  SSI–
2T.U. /0.1 ml Statens Serum Institut, Copenhagen, Denmark)
[22]. The resultant induration was measured at 72 h with a
ruler  by  an  independent  observer,  and  it  was  considered
positive if ≥15 mm (as validated in our population) [23]. IGRA
tests such as QuantiFERON-TB Gold In-Tube (QFT; Cellestis
Inc.,  Carnegie,  Australia)  and  T-SPOT.TB  (Oxford
Immunotec, Abingdon, UK) were performed according to
guidelines, and blood samples taken before each TST was
performed [24,25]. Uveitis associated with TB (TAU) was
defined as a positive TST with a positive IGRA and no other
cause found to contribute to the ocular inflammation, as well
as response to anti-TB therapy [26,27].
Aqueous  humor  sampling:  Before  any  treatment  was
started, aqueous humor was sampled from the eye with more
severe active inflammation, using a described technique [28].
Briefly, we performed the procedure under topical anesthesia,
using an aseptic technique: a 27-gauge needle attached to an
insulin syringe was inserted at the peripheral clear cornea in
a plane above and parallel to the iris. Under direct vision aided
by a slit-lamp, approximately 100 µl of aqueous fluid were
withdrawn. All patients were re-examined at 30 min and one
week after the procedure, with topical antibiotics prescribed
for three days. Aqueous humor was also sampled from the
non-inflammatory controls under an operating microscope,
using  the  technique  described,  just  before  commencing
cataract surgery. Aqueous samples were immediately spun at
300× g for five min at 4 °C, using a tabletop microcentrifuge,
and stored at –80 °C until analysis.
Cytokine measurement: Bio-Plex Pro™ magnetic color-
bead-based  multiplex  assay  (Bio-Rad  Laboratories,  Inc.,
Hercules,  CA)  was  used  to  measure  aqueous  cytokine
concentrations.  Thirty-five  microliters  (35  µl)  of  each
aqueous humor sample were used. Fluorescence intensity (FI)
from the immunoassay was acquired and analyzed using the
Bio-Plex™  200  System  (software  version  6.0;  Bio-Rad
Laboratories, Inc.).
Statistical analysis: Statistical analysis was performed
using Statistica Version 6.0 (Statsoft, Tulsa, OK). Statistical
significance  was  set  at  p<0.05.  For  categorical  variables,
frequency  distribution  and  percentages  were  calculated.
Comparisons of baseline characteristics were conducted by
Fisher’s exact tests. To compare the differences in cytokine
concentrations,  a  Mann–Whitney  U  test  with  Bonferroni
correction was performed. In addition, multivariate binary
logistic regression analysis was performed to adjust for the
differences in age, gender, and ethnic group. The two-tailed,
nonparametric  Spearman  method  was  used  to  assess  for
correlations between variables.
Classification  analysis:  Step-wise  analysis  was
performed to generate cytokine profiles to best separate the
different disease groups. For each cytokine, the measured
concentration  was  logarithmically  transformed.  An  initial
analysis was used on all available cytokines and chemokines,
and then it was refined to include those that showed significant
differences  on  two-sample  Student’s  t-tests.  The  panel  of
differentially expressed cytokines was then further reduced by
the  removal  of  highly  correlated  cytokines.  A  separate
decision  tree  analysis  was  performed  to  step-wise  select
marker cytokines, using open-source data mining software
WEKA. Fivefold cross validation was conducted to examine
the error rate of this method.
RESULTS
Patient demographics and clinical findings: We enrolled 25
new patients who presented with acute, active uveitis, and who
were  suspected  of  having  TB  upon  initial  clinical
examination, with clinical signs consistent with TAU, such as
granulomatous  inflammation,  broad-based  posterior
synechiae, or retinal vasculitis, with or without choroiditis
[29,30] Based on the diagnostic criteria above, ten patients
had TAU, all of whom responded to anti-TB therapy. These
patients had a positive QFT (n=9), a positive T-SPOT.TB
(n=5), or both positive QFT and T-SPOT.TB (n=4); all had
TST indurations ≥15 mm (range 15–35 mm). After complete
clinical evaluations and investigations, it was determined that
the other 15 subjects with uveitis had no underlying cause or
disease, including negative TST (TST<10 mm) and negative
IGRA, with no other etiology found from the investigations
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566described  above;  as  such,  they  were  defined  as  having
idiopathic  uveitis  (IU).  Patient  demographic  data  are
presented in Table 1.
All uveitis patients had active inflammation with SUN
grade 1+ (n=10) or 2+ (n=16) anterior chamber cells at the
time of aqueous sampling. The patients had predominantly
anterior  (n=17),  intermediate  (n=2),  posterior  (n=3),  or
panuveitis (n=4). There were no cases of choroiditis. Only
four  patients  had  bilateral  disease;  three  of  those  had
panuveitis  and  one  had  anterior  uveitis.  Aqueous  PCR
analysis  was  performed  for  Mycobacterium  tuberculosis,
cytomegalovirus, herpes simplex virus, varicella-zoster virus,
rubella virus, and toxoplasmosis genomic DNA; the results
were negative for all samples.
Twenty-three patients who consulted for cataract surgery
were enrolled in the study as non-inflammatory controls. The
controls had no known systemic inflammatory, autoimmune,
or  immunosuppressive  disease,  as  well  as  no  pre-existing
ocular disease or previous ocular surgery.
Aqueous humor cytokine concentration: Table 2 describes the
concentrations of interleukin (IL)-2, interferon-gamma (IFN-
γ), IL-6, IL-10, IL-12, tumor necrosis factor alpha (TNF-α),
monocyte chemotactic protein-1 (CCL2), IL-8 (also known as
CXCL8),  monocyte  induced  by  interferon-gamma  (also
known as CXCL9 or IL-9), interferon-gamma induced protein
10 (IP-10, CXCL-10), and IL-9 in aqueous samples from the
TAU, IU, and control groups. Calculated concentrations equal
to or lower than the low detection limit of the analysis for
individual  cytokine  were  taken  as  non-measurable.  By
univariate analysis, the TAU patients showed significantly
higher concentrations of IL-6 (p=0.047), CXCL8 (p=0.001),
CXCL9 (p=0.001), and CXCL10 (p=0.002), compared to the
non-inflammatory  controls.  However,  when  they  were
adjusted  for  age  and  gender  differences,  only  CXCL8
(p=0.043) showed significant differences between the TAU
patients  and  the  controls  (p=0.071  for  IL-6,  p=0.175  for
CXCL9, p=0.107 for CXCL10).
When the IU and cataract groups were compared using
univariate  analysis,  IU  showed  significantly  higher
concentrations of IL-6 (p=0.008), CCL2 (p=0.036), CXCL8
(p=0.001), and IL-9 (p=0.045), and lower concentrations of
IL-2  (p=0.011),  IL-12  (p=0.001),  and  TNF-α  (p=0.001),
compared to the controls. After multivariate analysis adjusted
for age and gender, the differences in IL-6 (p=0.050), CXCL2
(p=0.025), CXCL8 (p=0.025), IL-9 (p=0.015), and TNF-α
(p=0.050) remained significant. However, the differences in
IL-2  (p=0.164)  and  IL-12  (p=0.993)  were  no  longer
significant. Scatter plots of these cytokines are presented in
Figure 1. Between the TAU and IU groups, TAU had higher
IL-2  (p=0.004),  IL-12  (p=0.000),  TNFα  (p=0.001),  and
CXCL9 (p=0.007) levels by univariate analysis. However,
when adjusted by age and gender, only the difference in IL-12
(p=0.050) remained significant.
Classification analysis for TAU and IU: Heat map analysis
revealed a distinct panel of cytokines, composed of IL-6,
CXCL8, CXCL9, and CXCL10, to separate the TAU patients
from the non-inflammatory controls (Figure 2). The accuracy
of  this  classification  was  95%  for  the  non-inflammatory
controls and 67% for the TAU samples. The combination of
CCL2, CXCL8, and IL-6 separated the controls from the IU
group, with an accuracy of 80% for controls and 80% for IU
(Figure 3). The combination of IL-10, TNF-α, IL-12, and IL-2
separated the TAU group from the IU group, with an accuracy
of 80% for TAU and 93% for IU (Figure 4). The decision tree
analysis of all samples generated a mathematical classifier
model,  which  involved  three  cytokines:  IL-12,  IL-6,  and
CCL4.  A  further  fivefold  cross  validation  of  this  model
provided a correction rate of 77% for all samples tested.
DISCUSSION
The  immune  response  upon  active  Mycobacterium
tuberculosis infection is initiated by the recognition of the
bacteria, mainly by macrophage and DC cells through Toll-
like receptors, which stimulate the production of cytokines
TABLE 1. DEMOGRAPHIC FEATURES OF PATIENTS.
    Groups  
Characteristics All (n=48) TAU (n=10) IU (n=15) Controls (n=23) p-value*
Age (mean±SD) 57.8±18.4 41.1±20.9 55.8±13.7 66.3±15.0 0.001
Gender (%)
Male 21 (43.8) 4 (40.0) 6 (40.0) 11 (48.0) 0.678
Female 27 (56.3) 6 (60.0) 9 (60.0) 12 (52.0)  
Race (%)
Chinese 32 (66.7) 2 (20.0) 11 (73.3) 19 (82.6) 0.015
Malay 8 (16.7) 3 (30.0) 3 (20.0) 2 (8.6)  
Indian 4 (8.3) 2 (20.0) 1 (6.7) 1 (4.4)  
Others 4 (8.3) 3 (30.0) 0 (0.0) 1 (4.4)  
        TAU: Uveitis associated with tuberculosis; IU=Idiopathic uveitis; SD=Standard Deviation. *p-value was obtained from one-
        way ANOVA test or Pearson χ2 comparing TAU, IU and non-inflammatory controls.
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568such as IL-12 and TNF-α. IL-12 subsequently activates a Th1-
cell-dominated adaptive immune response, which is largely
responsible  for  containing  the  inflammation,  through  the
secretion of IFN-γ. Increased concentrations of IL-12, TNF-
α, and IFN-γ are hallmarks of active TB infection. However,
in  our  study,  heat-map  analysis  revealed  increased  IL-6,
CXCL8, CXCL9, and CXCL10 in the TAU group compared
to the non-inflammatory controls, and it is also distinct from
the  cytokine  profiles  of  idiopathic  uveitis.  These  results
suggest that TAU is a distinct entity from idiopathic uveitis,
and the cytokine profiles suggest that these patients with TAU
were unlikely to have active ocular TB infection.
Our heat-map analysis also revealed that CXCL9 and
CXCL10  are  increased  in  TAU,  findings  also  seen  in
autoimmune-related inflammation [31,32]. A previous study
described a patient who developed uveitis following Bacille-
Calmette-Guerin therapy for bladder cancer—an autoimmune
reaction against retinal proteins, which had sequences similar
Figure 1. Cytokine levels measured by multiplexed bead immunoassay in aqueous from TB associated uveitis (TAU,  closed  circles),
idiopathic uveitis (IdioU,   open    circles),  and non-inflammatory controls (squares). Mann-Whitney U      test with Bonferroni adjustment was 
performed to compare uveitis and control groups. A significant difference is set at p<0.05.
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569to  Mycobacterium  tuberculosis  proteins  [33].  These  are
consistent  with  previous  suggestions  that  the  ocular
inflammation observed in TAU patients could be due to a
mechanism similar to antigenic mimicry [25,34].
The identification of biomarkers in the aqueous humor
can potentially provide us with an alternative for diagnosing
conditions that may otherwise be considered as idiopathic in
patients  with  uveitis.  A  previous  study  has  shown  that
different  cytokine  profiles  are  associated  with  uveitis  of
specific  etiologies,  using  multivariate  analysis  of  aqueous
cytokine composition [15]. However, multivariate analyses
do not take into account the complicated intrinsic interactions
between cytokines. Therefore, we used step-wise analysis and
mathematical modeling with decision tree analysis, which
were consistent with those that showed significant differences
between groups by univariate analysis. In this study, we used
tests to identify panels of cytokines that distinguish TAU from
IU  and  non-inflammatory  controls.  By  deleting  highly
correlated cytokines and cytokines that were not significantly
different between groups, the analysis revealed a panel of
cytokines that distinguishes samples with TAU from non-
inflammatory  controls.  These  results  may  be  helpful  in
identifying key factors associated with each disease entity.
Our study is limited by the relatively small number of
subjects and the cross-sectional design, in which all subjects
had aqueous sampling and analysis during active disease.
Although  a  followup  aqueous  sample  after  the  treatment
would  give  us  more  insightful  information  regarding  the
Figure 2. Heat-map analysis comparing
uveitis  associated  with  tuberculosis
(TAU) and non-inflammatory controls.
A distinct panel of cytokines composed
of IL-6, CXCL8, CXCL9, and CXCL10
distinguishes both groups.
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570pathogenesis of the diseases, we did not consider it ethical to
sample  patients  during  quiescence.  However,  in  future
studies, it would be of great value to analyze the aqueous of
patients with TAU who develop cataract and need to undergo
surgery. Similarly, it would be ideal to sample aqueous from
eyes of healthy individuals with no ocular pathology to serve
as controls for future studies. We randomly recruited subjects
with uveitis and non-inflammatory controls, which led to a
significant  difference  in  the  mean  age  between  groups.
However, we did not find any significant changes when age
and gender differences were taken into consideration using
multivariate analysis.
In conclusion, our study showed that uveitis associated
with TB featured increased aqueous levels of IL-6, CXCL2,
CXCL8, CXCL9, and CXCL10, which is not typical of an
active ocular TB infection. On the other hand, the aqueous
humor  cytokine  profile  of  idiopathic  uveitis  suggested  a
dysregulated immune homeostasis, which is unlikely to be
incited by a pathogen. The altered cytokine concentrations
found in this study could lead to further discoveries regarding
the pathogenesis of both TAU and idiopathic uveitis.
Figure 3. Heat-map analysis comparing
idiopathic  uveitis  (IU)  and  non-
inflammatory  controls.  The
combination  of  CCL2,  CXCL8,  and
IL-6 separated controls from IU with
80% accuracy.
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